Skip to content
Screener

Evolus EOLS Total Equity

Total Equity at other companies

AbbVie logo
AbbVieABBV
-$6.66B-569%

Other financials

Income statement

See full
Revenue$84.1M+21.2%
Gross profit$57.2M+26.2%
Operating income-$4.5M+55.5%
Net income-$8.1M+53.0%
EPS (diluted)-$0.12+55.6%

Balance sheet

See full
Cash & equivalents$45.2M-26.8%
Total debt$164.8M+12.3%
Total assets$248.0M+8.4%

Cash flow

See full
Operating cash flow-$3.6M+85.5%
CapEx$50.0K-92.7%
Free cash flow-$3.6M+85.7%

Valuation

See full
Market cap$501.32M+31.4%
Enterprise value$620.96M+33.1%
P/S1.6×+0.2×

Profitability

See full
Gross margin66.7%-0.4pp
Operating margin-13.7%-1.9pp
Net margin-10.9%-3.7pp
FCF margin-9.6%-3.6pp

Returns & leverage

See full
Return on equity-472.6%-1,534pp
Debt / equity22.2×
Current ratio1.7×-0.6×

Where this comes from

Reported directly by Evolus in its filing.

Tagged under the XBRL concept us-gaap:StockholdersEquity.

The source filing: Evolus’s 10-Q, filed August 5, 2026. Open the filing →

Filed
Aug 5, 2026, 4:56 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-053468

FAQ

What is Evolus's total equity?
Evolus (EOLS) reported total equity of -$30.9M in Q2 2026.
How has Evolus's total equity changed year-over-year?
Evolus's total equity decreased by 65.7% year-over-year, from -$18.65M to -$30.9M.
What is the long-term trend for Evolus's total equity?
Over 5 years (2020 to 2025), Evolus's total equity has grown at a -20.5% compound annual growth rate (CAGR), from -$72.96M to -$23.11M.
What does total equity mean?
Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.

Ask your AI about Evolus's total equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude